Summary
Lili Du is a research scientist at MD Anderson Cancer Center with over a decade of experience at the intersection of medicine, pharmacology, and biostatistics, specializing in developing prediction models for cancer diagnosis and treatment. She holds an MBBS, an MS in Oncology, a PhD in Pharmacology, and an MS in Biostatistics, and combines deep domain knowledge in genomics and molecular biology with strong skills in large-data handling, study design, and high-performance computing. Lili has led collaborative, multidisciplinary projects from assay development to clinical and observational studies, and regularly authors manuscripts, grants, and protocols. Proficient in R, SAS, STATA, SQL and Linux (with working knowledge of Python and Perl), she translates complex bioinformatics analyses into actionable clinical insights. Colleagues value her ability to coordinate cross-institutional teams and to turn public and internal datasets into robust, reproducible predictive tools.
10 years of coding experience
Doctor of Philosophy (Ph.D.), Pharmacology, Doctor of Philosophy (Ph.D.), Pharmacology at Medical College of Wisconsin
MS, Oncology, MS, Oncology at Nanjing University
Master's degree, Biostatistics, Master's degree, Biostatistics at The University of Texas Health Science Center at Houston (UTHealth Houston)
MBBS, Medicine, MBBS, Medicine at Jiangsu University
English, Chinese